Recent News

• 11.10.2025 - Immunocore to present at upcoming investor conferences
• 11.07.2025 - Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
• 11.06.2025 - Immunocore reports third quarter financial results and provides a business update
• 09.04.2025 - Immunocore to present at upcoming investor conferences
• 08.07.2025 - Immunocore reports second quarter financial results and provides a business update

Recent Filings

• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 10.24.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 10.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors